12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Architect AFP regulatory update

FDA approved Abbott's Architect AFP test as an aid in monitoring disease progression in patients with nonseminomatous testicular cancer and an aid...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >